RxDoctor Payments DataLook up a doctor →

Joseph Orallo, APRN

Nurse Practitioner · Jacksonville Beach, FLNPI 1306379847

Payments from drug & device makers

$22,256in general payments, 2019–2025

Across 884 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Novo Nordisk$2K
  • AbbVie$2K
  • Amgen$2K
  • GSK$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • plus $9K from 50 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca66$4,100
Novo Nordisk111$2,360
AbbVie164$2,256
Amgen87$1,982
GSK83$1,762
Biohaven Pharmaceuticals, Inc.10$1,203
Lilly USA, LLC59$1,169
Pfizer51$805
Johnson & Johnson13$739
Boehringer Ingelheim31$595
Abbott18$552
Merck24$491
Phathom Pharmaceuticals, Inc.11$423
Vanda Pharmaceuticals Inc.17$355
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$302
Axsome Therapeutics, Inc.5$282
Exact Sciences9$233
Amarin Pharma, Inc.16$221
Novartis12$205
Boston Scientific2$186
Biohaven Pharmaceutical Holding Company Ltd.6$164
Daiichi Sankyo Inc.3$157
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$156
Otsuka America Pharmaceutical, Inc.2$148
Abiomed1$131
Imperative Care, Inc1$109
Idorsia Pharmaceuticals US Inc7$107
Vivus LLC5$90
Xeris Pharmaceuticals, Inc.4$90
Bayer4$76
Eisai Inc.4$65
Esperion Therapeutics, Inc.3$63
Medtronic3$62
Radius Health, Inc.3$59
Sanofi-aventis U.S. LLC3$47
Sanofi Pasteur Inc.2$41
Cequr Corporation1$39
Hikma Pharmaceuticals USA2$35
Dynavax Technologies Corporation1$34
Clarus Therapeutics Inc.4$34
Neos Therapeutics, LP2$32
Sumitomo Pharma America, Inc.2$32
Antares Pharma, Inc.1$30
Kowa Pharmaceuticals America, Inc.2$28
Dexcom, Inc.2$27
Genentech USA, Inc.1$20
Inspire Medical Systems, Inc.1$19
Cvrx, Inc.1$19
Endo Pharmaceuticals Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17
Almatica Pharma LLC1$16
Eyevance Pharmaceuticals LLC1$16
Jazz Pharmaceuticals Inc.1$15
Amneal Pharmaceuticals LLC1$13
IBSA Pharma Inc.1$13
Arbor Pharmaceuticals, Inc.1$13

How this compares

$22,256 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024
$90,148
Medicare patients
485
Services billed
3,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Jacksonville Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →